Trade Summary

6 days ago, Sukhatme Mayukh, serving as President & CIO at Roivant Sciences Ltd. (ROIV), sold 1,000,000 shares at $34.11 per share, for a total transaction value of $34,105,000.00. Following this transaction, Sukhatme Mayukh now holds 18,677,617 shares of ROIV.

This sale represents a 5.08% decrease in Sukhatme Mayukh's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 6:23 PM ET, 4 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.